Viewing Study NCT02867956


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-02-08 @ 6:10 AM
Study NCT ID: NCT02867956
Status: COMPLETED
Last Update Posted: 2020-12-04
First Post: 2016-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian cancer View
None Apatinib View
None Etoposide View
None Chemotherapy View